1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Freret, M. E.; Tringale, K. R.; Boe, L.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schöder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • High-grade undifferentiated pleomorphic sarcoma masquerading as acquired lymphangioma circumscriptum
    Miscellaneous

    Rambhia, P. H.; D’angelo, S. P.; Shah, P. R.
    SKIN: Journal of Cutaneous Medicine (2023)

    Fulltext@MSK | Save
  • Novel therapeutics in ovarian cancer: Expanding the toolbox
    Review

    Moufarrij, S.; O'Cearbhaill, R. E.
    Current Oncology (2023)

    Fulltext@MSK | Save
  • Role of ERK1/2 kinases in megakaryopoiesis, thrombopoiesis, platelet function and thrombosis in myeloproliferative neoplasms
    Meeting Abstract

    Albrecht, C.; Stivala, S.; Vokalova, L.; Knopp, T.; Angelillo-Scherrer, A.; Levine, R.; Neel, B.; Meyer, S.
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Growth differentiation factor 15, a potential biomarker and a therapeutic target in myeloproliferative neoplasms
    Meeting Abstract

    Uda, N. R.; Stüdle, C.; Müggler, A.; Ueltschi, O.; Brunner, M.; Silzle, T.; Joachim, W.; Leković, D.; Lee, S. J.; Vannucchi, A. M.; more...
    Swiss Medical Weekly (2023)

    Fulltext@MSK | Save
  • Patterns of failure in 559 primary central nervous system lymphoma patients treated from 1983-2020
    Meeting Abstract

    Tringale, K.; Yahalom, J.; Scordo, M.; Grommes, C.; Imber, B.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Consolidation patterns and associated outcomes for a large cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B.; Tringale, K.; Scordo, M.; Yahalom, J.; Grommes, C.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Patient selection using genetic alterations associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Lee, J.; Fregonese, B.; Tringale, K.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Primary overall survival (OS) analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in relapsed/refractory large B-cell lymphoma (R/R LBCL)
    Meeting Abstract

    Dreger, P.; Westin, J.; Oluwole, O.; Kersten, M. J.; Miklos, D.; Perales, M. A.; Ghobadi, A.; Rapoport, A.; Sureda, A.; Jacobson, C.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save